Valvdre
Thank you for registering! Below are the login details to access the meeting. September 25 Meeting Topic: CryoLife Seminar Time: Sep 25, 2021 10:00 AM…
Read More...Ronda Horstman elected to Chairperson Elect of the American Association of Tissue Banks (AATB)
Ronda Horstman, Vice President, Donor Services, has received the distinct honor and high privilege of being elected to the position of Chairperson-Elect of the American Association of Tissue Banks (AATB)…
Read More...CryoLife Completes Acquisition of JOTEC
December 1, 2017 at 5:04 PM EST ATLANTA, Dec. 1, 2017 /PRNewswire/ — CryoLife, Inc. (NYSE: CRY), a leading medical device and tissue processing company focused on cardiac and vascular surgery, announced today that…
Read More...CryoLife Announces Enrollment of First Patients in BioGlue® Clinical Trial in China
November 6, 2017 at 5:04 PM EST ATLANTA, Nov. 6, 2017 /PRNewswire/ — CryoLife, Inc. (NYSE: CRY), a leading medical device and tissue processing company focused on cardiac and vascular surgery, announced today that enrollment…
Read More...CryoLife Reports Third Quarter 2017 Results
October 30, 2017 at 5:30 PM EDT ATLANTA, Oct. 30, 2017 /PRNewswire/ — Third Quarter and Recent Highlights: Announced Definitive Agreement to Acquire JOTEC Accelerated Enrollment in PerClot Clinical Trial Achieved Third…
Read More...CryoLife Announces Release Date and Teleconference Call Details for 2017 Third Quarter Financial Results
October 17, 2017 at 5:04 PM EDT ATLANTA, Oct. 17, 2017 /PRNewswire/ — CryoLife, Inc. (NYSE: CRY), a leading medical device and tissue processing company focused on cardiac and vascular surgery, announced today that…
Read More...CryoLife Announces Definitive Agreement to Acquire JOTEC
Visit JOTEC Provides Access into $2 Billion Global Stent Graft Market with Highly Competitive Technologically Advanced Product Portfolio Adds Robust New Product Pipeline and Significantly Enhances R&D Capabilities Accelerates…
Read More...CryoLife Announces On-X Aortic Heart Valve PROACT Study Results to be Presented at AATS Centennial Meeting
CryoLife, Inc. (NYSE: CRY), announced today that results from the On-X aortic heart valve PROACT study will be presented in a late-breaking session at the American Association for Thoracic Surgery…
Read More...CryoLife Acquires On-X Life Technologies
ATLANTA, Jan. 20, 2016 /PRNewswire/ — CryoLife, Inc. (NYSE: CRY), a leading medical device and tissue processing company focused on cardiac and vascular surgery, announced today that it has completed its previously…
Read More...